Quilter Plc’s Hepion Pharmaceuticals HEPA Stock Holding History

Quilter Plc’s Portfolio HEPA Stock Details HEPA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11	Closed	-$17K	–	221
2021 Q3	$17K	Hold	11	–	–	﹤0.01%	339
2021 Q2	$22K	Hold	11	–	–	﹤0.01%	357
2021 Q1	$20K	Buy	+11	New	+$24.1K	﹤0.01%	354

Other funds holding HEPA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Quilter Plc's HEPA Position: Q4 2021 in Review

Quilter Plc sold out of Hepion Pharmaceuticals (HEPA) in Q4 2021, closing a stake of 11 shares — an estimated $17K sold.

Quilter Plc first reported a position in HEPA in Q1 2021 and held it in 3 quarters. The position peaked at $22K in Q2 2021. 39 funds tracked by Wall St. Rank hold HEPA as of Q4 2021.

Quilter Plc reported no remaining Hepion Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Quilter Plc sold 11 Hepion Pharmaceuticals shares in Q4 2021, an estimated $17K.
Quilter Plc first reported a position in Hepion Pharmaceuticals in Q1 2021 and held it in 3 quarters.
Quilter Plc's Hepion Pharmaceuticals position peaked at $22K in Q2 2021.
39 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q4 2021.

Based on Quilter Plc's 13F filing for Q4 2021, filed 14 Feb 2022.